Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06171269
NA

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

Sponsor: University of Chicago

View on ClinicalTrials.gov

Summary

The purpose of this research is to gather information on the safety and effectiveness of using an imaging technique called magnetic resonance imaging (MRI) to decrease radiation dose to the uninvolved prostate (areas of the prostate that do not clearly have cancer cells) while increasing radiation dose to the nodules (hardened areas of the prostate that have cancer cells).

Official title: A Prospective Study of Lower Dose Radiation (LO-RADS) for Prostate Cancer Using MRI Dose Mapping to Preserve Quality of Life

Key Details

Gender

MALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-01-05

Completion Date

2028-10-20

Last Updated

2026-03-04

Healthy Volunteers

No

Conditions

Interventions

RADIATION

Radiation

Radiation to the prostate gland will be given daily (Mon-Friday) for 4 weeks.

RADIATION

MRI

The study doctor will use an MRI scan to take pictures of the prostate gland. These images of the prostate gland will let the study doctor know which areas of the prostate contain cancer cells that need to be targeted with higher doses of radiation and which uninvolved areas to target with lower doses of radiation.

OTHER

Androgen Deprivation Therapy

Treatment of treating physician choice will be given for 6-24 months.

Locations (1)

University of Chicago Medicine Comprehensive Cancer Center

Chicago, Illinois, United States